Смотреть в Telegram
BioNTech RNA-Based COVID-19 Injections Contain Large Amounts Of Residual DNA Including An SV40 Promoter/Enhancer Sequence https://t.co/OpMLZ2WPZN — Wolfgang Wodarg (@wodarg) Dec 3, 2024
December 03, 2024 at 11:02PM
via Twitter https://twitter.com/wodarg
Für Ihre gesundheit @WolfgangWodarg - Gegen Spam das @Antispamsystem
Science, Public Health Policy and the Law
BioNTech RNA-Based COVID-19 Injections Contain Large Amounts Of Residual DNA Including An SV40 Promoter/Enhancer Sequence - Science…
Background: BNT162b2 RNA-based COVID-19 injections are specified to transfect human cells to efficiently produce spike proteins for an immune response.
Love Center - Dating, Friends & Matches, NY, LA, Dubai, Global
Бот для знакомств